Plasma levels of alpha1-antichymotrypsin and secretory leukocyte proteinase inhibitor in healthy and chronic obstructive pulmonary disease (COPD) subjects with and without severe α1-antitrypsin deficiency

BACKGROUND: Individuals with severe Z α1-antitrypsin (AAT) deficiency have a considerably increased risk of developing chronic obstructive lung disease (COPD). It has been hypothesized that compensatory increases in levels of other protease inhibitors mitigate the effects of this AAT deficiency. We...

Descripción completa

Detalles Bibliográficos
Autores principales: Hollander, Camilla, Westin, Ulla, Wallmark, Anders, Piitulainen, Eeva, Sveger, Tomas, Janciauskiene, Sabina M
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2007
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1800898/
https://www.ncbi.nlm.nih.gov/pubmed/17261175
http://dx.doi.org/10.1186/1471-2466-7-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1800898/
https://www.ncbi.nlm.nih.gov/pubmed/17261175
http://dx.doi.org/10.1186/1471-2466-7-1

Ejemplares similares